| Biovest International product gets orphan drug status from FDA The U.S. Food and Drug Administration has granted orphan drug designation to BiovaxID for the treatment of mantle cell lymphoma. feeds.bizjournals.com |
S&P lowers WellCare Health Plans outlook Standard & Poor’s Ratings Service revised its outlook on WellCare Health Plans Inc. to stable from positive. (WCG) feeds.bizjournals.com |
Court approves Gerdau Ameristeel deal The Ontario Superior Court of Justice issued a final order approving the acquisition of Gerdau Ameristeel Corp. (GNA) (GGB) feeds.bizjournals.com |
AreoThrust sold for $5M Miami-based jet engine maintenance company AeroThrust Corp., which filed for Chapter 11 bankruptcy in late 2009, has been sold intact for $5 million to a group led by Miami-based Air Capital Group LLC. feeds.bizjournals.com |
Saneron, USF get $2.6M grant for Alzheimer’s work The National Institutes of Health awarded a three-year, $2.6 million grant to the University of South Florida and Saneron CCEL Therapeutics Inc. for an effort that ultimately could lead to new treatment for Alzheimer’s disease. feeds.bizjournals.com |